1. Prat J. FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014; 124:1–5.
2. Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 2014; 133:401–404.
3. Prat J. FIGO Committee on Gynecologic Oncology. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol. 2015; 26:87–89.
4. Prat J. FIGO Committee on Gynecologic Oncology. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum. Eur J Obstet Gynecol Reprod Biol. 2015; 188:133–135.
5. Prat J, Belhadj H, Berek J, Bermudez A, Bhatla N, Cain J, et al. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum. Eur J Gynaecol Oncol. 2015; 36:367–369.
6. Prat J. FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication of guidelines from the International Federation of Gynecology and Obstetrics (FIGO). Obstet Gynecol. 2015; 126:171–174.
7. Prat J. FIGO Committee on Gynecologic Oncology. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum. Cancer. 2015; 121:3452–3454.
8. Prat J. Ovarian, fallopian tube and peritoneal cancer staging: rationale and explanation of new FIGO staging 2013. Best Pract Res Clin Obstet Gynaecol. 2015; 29:858–869.
9. Inoue K, Tsubamoto H, Hao H, Tamura K, Hashimoto-Tamaoki T. Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: a case report. Gynecol Oncol Case Rep. 2013; 5:61–63.
10. Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002; 87:52–56.
11. Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007; 25:3985–3990.